ArriVent BioPharma, Inc. AVBP Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by ArriVent BioPharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShortTermInvestments.
The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about ArriVent BioPharma, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ArriVent BioPharma, Inc.'s short-term investments?
- ArriVent BioPharma, Inc. (AVBP) reported short-term investments of $264.28M in Q1 2026.
- How has ArriVent BioPharma, Inc.'s short-term investments changed year-over-year?
- ArriVent BioPharma, Inc.'s short-term investments increased by 109.4% year-over-year, from $126.21M to $264.28M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.